EuropaBio publishes biotech industry evaluation11/09/17Science & Technology
EuropaBio issued its evaluation of the EU’s progress on creating an innovative environment to attract investment and foster jobs, growth and competitiveness.
John Brennan, EuropaBio secretary general, said that “critical geopolitical issues, requiring the attention of Europe’s policy makers, have understandably dominated policy discussion and actions.
“Yet the policy imperative of delivering economic progress is still there, and a strong EU economy is a prerequisite if we are to meet these global challenges. We therefore urge EU policymakers to put ambitious innovation policies and jobs and growth back at the heart of their agenda.”
The European Association for Bioindustries evaluation looks forward, illustrating achievable and non-legislative approaches to guaranteeing results under the commission’s remaining mandate.
The association aims to: back an update of Europe’s Bioeconomy Strategy; an holistic, balanced approach to biotech innovation under the current incentives; and an efficient implementation of the existing GMO authorisation system.
Further, key barriers which could prevent difficulties in achieving the full potential of the sector are presented in the report, which illustrates clear recommendations of how to overcome them.
Brennan added: “Bioindustries contribute so much to the EU economy, creating useful products, jobs and growth. If we could couple that with an ambitious EU policy agenda, we can contribute even more to tackling our societal challenges in these next two years.”